Health Canada drug identification number

DIN 02401975 — TRI-CIRA LO 28 0.025 MG; 0.025 MG; 0.215 MG; 0.25 MG; 0.025 MG; 0.18 MG

TRI-CIRA LO 28 is a tablet of Ethinyl Estradiol / Norgestimate marketed by APOTEX INC. The full Ethinyl Estradiol / Norgestimate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02401975
Brand name
TRI-CIRA LO 28
Strength
0.025 MG; 0.025 MG; 0.215 MG; 0.25 MG; 0.025 MG; 0.18 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
APOTEX INC
Health Canada status
MARKETED
Drug class
Estrogen-progestin combination (combined oral contraceptive, triphasic)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Ethinyl Estradiol / Norgestimate products

DINBrandStrengthFormManufacturerStatus
02508087 TRI-CIRA 21 0.25 MG; 0.035 MG; 0.18 MG; 0.035 MG; 0.035 MG; 0.215 MG TABLET APOTEX INC MARKETED
02508095 TRI-CIRA 28 0.215 MG; 0.25 MG; 0.18 MG; 0.035 MG; 0.035 MG; 0.035 MG TABLET APOTEX INC MARKETED
02401967 TRI-CIRA LO 21 0.025 MG; 0.025 MG; 0.215 MG; 0.25 MG; 0.025 MG; 0.18 MG TABLET APOTEX INC MARKETED
02486296 TRI-JORDYNA 21 0.035 MG; 0.035 MG; 0.035 MG; 0.18 MG; 0.215 MG; 0.25 MG TABLET GLENMARK PHARMACEUTICALS CANADA INC. MARKETED
02486318 TRI-JORDYNA 28 0.18 MG; 0.035 MG; 0.035 MG; 0.035 MG; 0.25 MG; 0.215 MG TABLET GLENMARK PHARMACEUTICALS CANADA INC. MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.